Oak Thistle LLC Has $2.11 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Oak Thistle LLC boosted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 1,042.9% in the 4th quarter, Holdings Channel.com reports. The firm owned 7,040 shares of the company’s stock after acquiring an additional 6,424 shares during the quarter. HCA Healthcare makes up about 0.6% of Oak Thistle LLC’s investment portfolio, making the stock its 22nd biggest position. Oak Thistle LLC’s holdings in HCA Healthcare were worth $2,113,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. American Century Companies Inc. grew its holdings in shares of HCA Healthcare by 60.0% during the second quarter. American Century Companies Inc. now owns 23,024 shares of the company’s stock worth $7,397,000 after purchasing an additional 8,633 shares during the last quarter. Brown Brothers Harriman & Co. increased its position in HCA Healthcare by 279.3% in the 2nd quarter. Brown Brothers Harriman & Co. now owns 2,902 shares of the company’s stock valued at $932,000 after acquiring an additional 2,137 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of HCA Healthcare by 2.3% during the second quarter. Dimensional Fund Advisors LP now owns 520,835 shares of the company’s stock worth $167,426,000 after purchasing an additional 11,861 shares during the period. One Capital Management LLC acquired a new stake in HCA Healthcare in the second quarter valued at $662,000. Finally, Mesirow Financial Investment Management Inc. bought a new stake in shares of HCA Healthcare in the 2nd quarter valued at about $209,000. 62.73% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on HCA shares. TD Cowen dropped their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Truist Financial cut their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Finally, Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price objective for the stock from $400.00 to $320.00 in a research report on Monday, November 25th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $385.27.

HCA Healthcare Stock Down 0.8 %

Shares of NYSE:HCA opened at $305.63 on Wednesday. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The business’s 50 day moving average is $319.34 and its 200 day moving average is $353.44. HCA Healthcare, Inc. has a 12-month low of $276.50 and a 12-month high of $417.14. The stock has a market cap of $77.42 billion, a price-to-earnings ratio of 13.72, a PEG ratio of 1.21 and a beta of 1.64.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s payout ratio is currently 11.85%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.